Primary Central Nervous System Vasculitis Diagnosis and Treatment

Primary central nervous system vasculitis (PCNSV) is an uncommon inflammatory disorder confined to the brain and spinal cord vasculature. It presents with a heterogeneous constellation of symptoms including persistent headache, seizures, cognitive decline and focal neurological deficits. The pathogenesis remains poorly understood, but histopathology typically reveals lymphocytic or granulomatous infiltration of small- and medium-sized vessels. Diagnosis relies on a combination of clinical evaluation, cerebrospinal fluid analysis, advanced neuroimaging and, in many cases, brain biopsy. Vessel wall imaging with high-resolution MRI can demonstrate characteristic enhancement and stenosis, while digital subtraction angiography remains the gold standard for detecting multifocal beading in larger vessels. Cerebrospinal fluid often shows elevated protein and mild pleocytosis but lacks specificity. Invasive stereotactic brain biopsy provides definitive histological confirmation and may distinguish mimics such as infection or neoplasm. Treatment centres on high-dose corticosteroids with adjunctive immunosuppressants—most commonly cyclophosphamide or rituximab—to induce remission and prevent relapse. Early recognition and prompt initiation of therapy are crucial, as delays are associated with poorer functional outcomes and increased morbidity. Long-term follow-up with serial imaging and clinical assessment guides tapering of immunosuppression and detection of recurrence.

Research from Nature Portfolio

Recent cohort analysis of biopsy- or angiography-proven PCNSV enrolled over 80 patients and highlighted key prognostic factors. The median diagnostic delay approached two years, underscoring the insidious onset of disease. Seizures were the most frequent presenting symptom, and susceptibility-weighted MRI sequences revealed microhaemorrhages in all cases. The lymphocytic histological subtype predominated, correlating with better response to therapy. Combined corticosteroid and cyclophosphamide treatment achieved favourable functional outcomes (modified Rankin Scale ≤2) in around two-thirds of patients at two years. Poorer recovery was linked to myelitis at onset and longer time to diagnosis. The presence of haemorrhages on advanced MRI emerged as a potential imaging marker of active vasculitis. The study emphasises the need for multicentre trials to compare immunosuppressive regimens and refine predictive models for outcome.

Primary Central Nervous System Vasculitis Diagnosis and Treatment publication trend

The graph below shows the total number of articles in primary central nervous system vasculitis diagnosis and treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Primary central nervous system vasculitis (PCNSV): An isolated inflammatory vasculopathy affecting cerebral and spinal vessels without systemic involvement.

Vessel wall enhancement: Contrast uptake in the arterial wall on high-resolution MRI indicating inflammatory activity.

Digital subtraction angiography (DSA): An invasive imaging technique that visualises blood vessel lumen by subtracting pre-contrast images from contrast-enhanced ones.

Stereotactic brain biopsy: A minimally invasive neurosurgical procedure that obtains tissue samples from targeted brain regions using three-dimensional coordinates.

Translocator protein-PET (TSPO-PET): Positron emission tomography targeting microglial/macrophage activation via radiotracers binding the 18 kDa translocator protein.

Susceptibility-weighted imaging (SWI): An MRI sequence sensitive to magnetic susceptibility differences, useful for detecting microhaemorrhages.

References

1. Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment. Insights into Imaging (2024).
2. Primary CNS vasculitis (PCNSV): a cohort study. Scientific Reports (2022).
3. Extended stereotactic brain biopsy in suspected primary central nervous system angiitis: good diagnostic accuracy and high safety. Journal of Neurology (2020).
4. Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system. European Journal of Nuclear Medicine and Molecular Imaging (2020).